FIELD: chemistry.
SUBSTANCE: invention represents method of preparing viscoelastic protector of corneal endothelium, including dissolution of initial therapeutic component with excessive viscosity in phosphate buffer, filtration and sterilisation until required viscosity value is obtained, characterized by the fact that as initial therapeutic component used is 3% solution of native hyaluronic acid, after dissolution 1% peptide complex, consisting of amino acid desmosine and following short-chained peptides-oligopeptides: GlyTrpIle; IleAspIle; PheArgPro; GlnHisHis; ProHisTyr; ThrTrpTrp; LysPheThr; LysArgMet; PheCysMet; IleIle; AspLysLys; TrpPro; GluThr, is introduced, and sterilisation is carried out by ionizing radiation in the range of radioactive radiation from 78×107 Mrad to 11×108 Mrad.
EFFECT: recovery of biochemical processes in endothelial layer of cornea with constant eye cornea moistening and increase of biocompatibility, which contributes to fast rehabilitation after traumas or surgery.
2 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREPARING VISCOELASTIC PROTECTOR OF CORNEAL ENDOTHELIUM | 2003 |
|
RU2234310C1 |
COMPLEX COSMETIC AGENT | 2013 |
|
RU2524663C1 |
PHARMACOLOGICALLY ACTIVE SUBSTANCE FOR OPHTHALMOLOGY | 2004 |
|
RU2272635C1 |
METHOD FOR PROTECTING INTERNAL OCULAR STRUCTURES AGAINST ULTRASOUND IMPACT AT PHACOEMULSIFICATION | 1999 |
|
RU2193375C2 |
IRRIGATION SOLUTION FOR OPHTHALMOLOGY | 2005 |
|
RU2288702C1 |
PRESERVING AGENT FOR DONOR CORNEA | 2010 |
|
RU2450515C1 |
METHOD FOR SOLUTION PREPARATION AND SOLUTION FOR TREATMENT AND PREVENTION OF KERATODERMA DISEASES AND INJURIES | 2006 |
|
RU2336862C2 |
PHARMACEUTICAL ANTIANGIOGENIC COMPOSITION FOR TREATING EYE DISEASES | 2013 |
|
RU2526825C1 |
PHARMACEUTICAL COMPOSITION FOR TREATING INFLAMMATORY DISEASES AND EYE CORNEA INJURIES | 2004 |
|
RU2259833C1 |
METHOD FOR OBTAINING SCLEROPLANT BIOMATERIAL USABLE IN OPHTHALMOLOGY | 2005 |
|
RU2290899C1 |
Authors
Dates
2014-12-10—Published
2013-08-20—Filed